Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
277
天
Safety Analysis of Pazopanib in Advanced and Metastatic Renal Cell Carcinoma: Insights From a Real‐World Pharmacovigilance Study
作者
Frederico Fonseca; Lília Leonardo; Alexandre Baptista; Liliana Pedro; Maria Luísa Pereira; Nuno Landeiro; Margarida Espírito‐Santo展开收起
作者单位
1. University of Évora; 2. Unidade Local de Saúde do Alentejo Central; 3. Unidade Local de Saúde do Algarve; 4. Algarve Biomedical Center; 5. University of Algarve; 6. Unidade Hospitalar de Portimão展开收起
214
天
Adverse Drug Events Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy: A Pharmacovigilance Analysis Based on Real‐World Data
作者
Lu Wang; Rui Xiong; Hengxu Liu; Shipeng Zhang; Yongtao Tong; Guangtao Hu; Xiaodan Lai展开收起
作者单位
1. Army Medical University; 2. Chinese People's Liberation Army; 3. Department of Pharmacy , No. 956 Hospital of PLA Army , Linzhi , 860000 , China展开收起
175
天
Modified Guizhi Plus Huangqi Decoction Improves Antiphospholipase A2 Receptor Antibody–Induced Podocyte Injury Through Modulating Autophagy‐Related Markers via AMPK/mTOR Pathway
作者
Manxia Huang; Yangpu Li; Zhishu Yang; Yunxin Lin; Zhuoting Liu; Zilan Jiang; Tingting Tan; Xinhui Liu; Youjia Zeng展开收起
作者单位
1. Guangzhou University of Chinese Medicine; 2. Shenzhen Traditional Chinese Medicine Hospital; 3. Tianjin University of Traditional Chinese Medicine展开收起
279
天
280
天
FAQ
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS审稿要多久?
截至2026-11-18,CrushSCI 收录了 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 的 5 篇完整审稿记录。最快一篇从收稿到录用用了 175 天(Modified Guizhi Plus Huangqi Decoction Improves Antiphospholipase A2 Receptor Antibody–Induced Podocyte Injury Through Modulating Autophagy‐Related Markers via AMPK/mTOR Pathway,2025-08-07 收稿,2026-01-29 录用),最慢一篇用了 280 天;平均 245 天,中位数 277 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
